跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 13,240 条关于
“Hangseo Pharmaceutical”
全部
13,240
临床试验
534
药物
1,662
机构
2,163
资讯
8,881
去年
HLB Group to Resubmit Riboceranib for FDA Approval Following Second Rejection
去年
HanAll, Daewoong, and NurrOn Announce Positive Phase 1 Results for Parkinson's Disease Therapy HL192 (ATH-399A)
去年
Pharmaceutical R&D Highlights: Key Clinical Updates from November 2024
去年
Lilly Expands Obesity Treatment Pipeline Through KeyBioscience Collaboration
去年
FDA Approves Bimzelx (bimekizumab-bkzx) for Moderate-to-Severe Hidradenitis Suppurativa
去年
SPIMA Therapeutics Launches with Focus on Peptide-Based Immunotherapies for Unmet Needs
去年
RAPT Therapeutics Licenses Novel Anti-IgE Antibody RPT904 for Global Development
去年
Merck & Co. to Acquire WuXi Biologics' Vaccine Facility in Ireland for $500 Million
去年
Shandong Xinhua Pharmaceutical Receives Approval for Pentazocine
去年
Strategic Intelligence Solutions Reshape Pharmaceutical Industry Decision-Making
第 1 页,共 889 页
上一页
下一页